Vaccines and treatments

OSU president Burns Hargis defends anthrax research cancellation decision
Hargis had ended an anthrax vaccine research project at OSU because it would have resulted in euthanizing baboons; he says he did not bow to pressures from animal rights activists – or from the wife of billionaire T. Boone Pickens, both OSU alumni and major donors to the school.
- Read more
Potent new biodefense technology shows promise
Medizone International’s AsepticSure technology continues to break the “6 log” decontamination barriers, this time with two very different spore forming bacteria, Claustridium difficile and Bacillis subtilis
- Read more

Oklahoma State rejects anthrax study over euthanasia of primates
The U.S. National Institutes of Health wanted OSU to conduct research on treatment for anthrax; the study involves baboons, which must be destroyed after anthrax exposure to ensure they do not infect others; In April, OSU announced that animals will no longer be euthanized in teaching labs at the veterinary school; measure was the result of pressure by Madeleine Pickens, the wife of billionaire benefactor and OSU alumnus T. Boone Pickens
- Read more
Experts call for changes in U.S. vaccine creation process
The current U.S. vaccine-manufacturing plan was developed prior to the cold war, and has never been updated; currently, the United States grows its vaccines in eggs over the course of six to eight months, and as there has been no real financial incentive to upgrade the vaccine making process, pharmaceutical manufacturers have instead focused on more profitable medications rather than vaccines
- Read more

Governments worry about more cases of drug-resistant H1N1
Health officials in the United Kingdom and the United States report the likely person-to-person spread of a drug-resistant strain of H1N1; most patients thus far infected with the strain have already been immune-deficient
- Read more
Bioterrorism poses new challenges for the health care systems worldwide
A new book points out to one of the essential challenges bioterrorism poses: Nations’ primary health care system must be prepared properly to cope with cases of exceptional morbidity due to uncommon generators
- Read more

UIC to develop antibiotics against potential bioterrorism agents
The University of Illinois at Chicago receives $4 million in stimulus package funds to develop new antibiotics to treat anthrax, tularemia and plague
- Read more
Ricin antidote ready for production
U.K. scientists develop the first antidote to ricin poisoning; security experts say ricin — roughly 1,000 times more toxic than cyanide — could be used in a bio-terror attack; what worries experts about ricin is not only its toxicity, but its ready availability: Ricin is extracted from castor beans, which are processed throughout the world to make castor oil; the toxin is part of the waste “mash” produced when castor oil is made
- Read more

NIAID allocated $208 million to fight emerging infectious diseases from bioterrorism
Using its own research funds, augmented by stimulus package money, NIH awarded $208 million to two programs that support research better to understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism
- Read more
Scientists track H1N1 virus for small changes which may mean big problems
A team at the University of California-San Francisco is using cutting-edge technology to track tiny genetic changes in H1N1 virus samples from around the word; what the scientists are worried about is a big change called genetic “shift,” when there is a dramatic re-assortment and exchange of strands of genetic material that trigger hard-to-predict epidemic trajectories
- Read more

Kent State to train lab workers for biocontainment
The increasing number of high-containment laboratories and the constant threat from emerging diseases and bioterrorism require more extensive biosafety training of the highest caliber, and more facilities in which to offer this training
- Read more
Tracking swine flu spread by monitoring electronic prescription records
Rhode Island is using information supplied by pharmacies to document how much Tamiflu and other antivirals are being dispensed to patients; the information — categorized by zip codes of the pharmacies where the medicine is dispensed and the age group of the patient receiving it — is given to epidemiologists at the state health department
- Read more

Uganda to conduct Marburg and Ebola vaccine trials
Ebola and Marburg are viral infections that have a high mortality, killing 90 percent of victims; no effective treatment exists for these highly infectious diseases, which cause extensive internal bleeding and rapid death
- Read more
Majority of Americans would refuse emergency use H1N1 vaccine or additive
Some 46 percent of people surveyed said they were concerned about
getting swine flu, but nearly 86 percent said they thought it was unlikely or very unlikely that they themselves would become ill
- Read more
University of California campuses on alert for swine flu outbreak
University of California campuses have been active informing students, faculty, and staff about swine flu; the medical centers on these campuses have emergency plans
- Read more

More headlines